• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深静脉血栓形成作为多发性骨髓瘤的首发表现:1例罕见病例报告及文献复习

DVT as the Initial Presentation of Multiple Myeloma: A Rare Case Report and Literature Review.

作者信息

Khalil Sondos K, Saeed Leena, Fadul Abdalla, Elawad Mohamed F, Ferih Khaled

机构信息

Internal Medicine Department, Hamad Medical Corporation, Doha, QAT.

Radiology, Hamad General Hospital, Doha, QAT.

出版信息

Cureus. 2023 Jul 28;15(7):e42600. doi: 10.7759/cureus.42600. eCollection 2023 Jul.

DOI:10.7759/cureus.42600
PMID:37644932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10461026/
Abstract

Multiple myeloma patients are recognized to have a higher risk of venous thrombosis. The cause of this could be attributed to several risk factors, such as circulating prothrombotic microparticles, disease-specific variables, and alterations in coagulation and fibrinolysis factors. Recent research has revealed that these individuals also experience greater arterial thrombosis, including acute myocardial infarction and stroke. In this case report, we present the clinical profile and management of a 42-year-old patient who presented with signs and symptoms of deep venous thrombosis (DVT) and was diagnosed with multiple myeloma. The aim of this case report is to highlight a rare clinical presentation and diagnostic workup in a patient with multiple myeloma. Additionally, we discuss the possible factors provoking the development of DVT as a first presentation before treatment initiation and their possible mechanisms.

摘要

多发性骨髓瘤患者被认为有更高的静脉血栓形成风险。其原因可归因于多种危险因素,如循环促血栓形成微粒、疾病特异性变量以及凝血和纤维蛋白溶解因子的改变。最近的研究表明,这些个体还更容易发生动脉血栓形成,包括急性心肌梗死和中风。在本病例报告中,我们介绍了一名42岁患者的临床情况及治疗过程,该患者出现了深静脉血栓形成(DVT)的体征和症状,并被诊断为多发性骨髓瘤。本病例报告的目的是强调多发性骨髓瘤患者一种罕见的临床表现和诊断检查。此外,我们还讨论了在开始治疗前引发DVT作为首发表现的可能因素及其可能机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/f1bac441bf0e/cureus-0015-00000042600-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/14eee4395c76/cureus-0015-00000042600-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/53170df8845c/cureus-0015-00000042600-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/f1bac441bf0e/cureus-0015-00000042600-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/14eee4395c76/cureus-0015-00000042600-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/53170df8845c/cureus-0015-00000042600-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df88/10461026/f1bac441bf0e/cureus-0015-00000042600-i03.jpg

相似文献

1
DVT as the Initial Presentation of Multiple Myeloma: A Rare Case Report and Literature Review.深静脉血栓形成作为多发性骨髓瘤的首发表现:1例罕见病例报告及文献复习
Cureus. 2023 Jul 28;15(7):e42600. doi: 10.7759/cureus.42600. eCollection 2023 Jul.
2
Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.性别、年龄和静脉血栓栓塞危险因素对首次孤立性症状性急性深静脉血栓形成初始表现的影响。
Thromb Res. 2019 Jan;173:166-171. doi: 10.1016/j.thromres.2018.09.056. Epub 2018 Sep 27.
3
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review.与类风湿关节炎相关的 Janus 激酶抑制剂的静脉血栓栓塞风险:病例报告和文献复习。
Clin Rheumatol. 2021 Nov;40(11):4457-4471. doi: 10.1007/s10067-021-05911-4. Epub 2021 Sep 23.
4
The Hospital Zambrano Hellion venous thromboembolism rapid response team (PREVENTION-team): Improving pulmonary embolism and deep venous thrombosis patient care.赞布拉诺·埃利翁医院静脉血栓栓塞快速反应小组(预防小组):改善肺栓塞和深静脉血栓形成患者的护理。
Arch Cardiol Mex. 2020;90(1):28-38. doi: 10.24875/ACM.19000276.
5
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.RIETE 登记研究中孤立性远端深静脉血栓与近端深静脉血栓患者的临床表现及短期和长期结局。
JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988.
6
The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.无诱因症状性深静脉血栓形成和无症状肺栓塞患者复发性静脉血栓栓塞的风险。
Thromb Haemost. 2006 Mar;95(3):562-6. doi: 10.1160/TH05-10-0677.
7
Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).肺栓塞和深静脉血栓形成后抗凝时间的差异:来自瑞士静脉血栓栓塞登记处(SWIVTER)的研究结果。
Thromb Res. 2022 Dec;220:65-71. doi: 10.1016/j.thromres.2022.10.006. Epub 2022 Oct 13.
8
Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.静脉血栓栓塞症:神经外科人群中的深静脉血栓形成和肺栓塞。
J Neurosurg. 2011 Jan;114(1):40-6. doi: 10.3171/2010.8.JNS10332. Epub 2010 Sep 3.
9
Risk and management of thrombosis in multiple myeloma.多发性骨髓瘤的血栓形成风险与管理。
Thromb Res. 2012 Apr;129 Suppl 1:S88-92. doi: 10.1016/S0049-3848(12)70024-5.
10
Pulmonary embolism and deep vein thrombosis: Similar but different.肺栓塞与深静脉血栓形成:相似但不同。
Thromb Res. 2021 Oct;206:88-98. doi: 10.1016/j.thromres.2021.08.015. Epub 2021 Aug 19.

引用本文的文献

1
Rediscovering hemostasis abnormalities in multiple myeloma: The new era.重新发现多发性骨髓瘤中的止血异常:新时代。
Heliyon. 2024 Jul 4;10(13):e34111. doi: 10.1016/j.heliyon.2024.e34111. eCollection 2024 Jul 15.
2
Inhibiting MMP13 Attenuates Deep Vein Thrombosis in a Mouse Model by Reducing the Expression of Pdpn.抑制 MMP13 通过降低 Pdpn 的表达减轻小鼠深静脉血栓形成。
Curr Med Sci. 2024 Apr;44(2):369-379. doi: 10.1007/s11596-024-2862-6. Epub 2024 Apr 15.

本文引用的文献

1
Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide.来那度胺治疗的多发性骨髓瘤患者发生肺静脉血栓形成
World J Oncol. 2021 Jun;12(2-3):73-76. doi: 10.14740/wjon1384. Epub 2021 May 14.
2
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.预测多发性骨髓瘤中的静脉血栓栓塞症:IMPEDE VTE 评分的建立和验证。
Am J Hematol. 2019 Nov;94(11):1176-1184. doi: 10.1002/ajh.25603. Epub 2019 Aug 19.
3
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma.
多发性骨髓瘤患者免疫调节药物相关血栓形成风险评估模型的推导和验证。
J Natl Compr Canc Netw. 2019 Jul 1;17(7):840-847. doi: 10.6004/jnccn.2018.7273.
4
Unusual Presentation of Multiple Myeloma.多发性骨髓瘤的不寻常表现
JNMA J Nepal Med Assoc. 2018 Jan-Feb;56(209):547-549. doi: 10.31729/jnma.3218.
5
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies: A Review.新型多发性骨髓瘤治疗的心血管和血栓并发症:综述。
JAMA Oncol. 2017 Jul 1;3(7):980-988. doi: 10.1001/jamaoncol.2016.3350.
6
Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.吸烟与静脉血栓栓塞风险:特罗姆瑟研究。
J Thromb Haemost. 2012 Oct;10(10):2068-74. doi: 10.1111/j.1538-7836.2012.04880.x.
7
Diabetes mellitus and thrombosis.糖尿病与血栓。
Thromb Res. 2012 Mar;129(3):371-7. doi: 10.1016/j.thromres.2011.11.052. Epub 2011 Dec 24.
8
Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis.来那度胺或沙利度胺治疗的多发性骨髓瘤患者的静脉血栓栓塞发生率:系统评价和荟萃分析。
J Thromb Haemost. 2011 Apr;9(4):653-63. doi: 10.1111/j.1538-7836.2011.04215.x.
9
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232).来那度胺联合高剂量地塞米松与地塞米松作为多发性骨髓瘤初始治疗的比较:西南肿瘤协作组随机试验(S0232)。
Blood. 2010 Dec 23;116(26):5838-41. doi: 10.1182/blood-2010-08-303487. Epub 2010 Sep 27.
10
Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.应用血栓弹力图检测 2 型糖尿病患者的高凝状态。
J Thromb Thrombolysis. 2011 Feb;31(2):165-72. doi: 10.1007/s11239-010-0506-0.